The European Union agreed to pay about 870 million euros ($1.06 billion) for its supply of 300 million doses of AstraZeneca’s COVID-19 vaccine and to receive them by June, the contract published by Italy’s RAI television shows. This is reported by Reuters.
The publication of the contract, signed on August 27, 2020, unveils confidential details about the price and the timetable for deliveries agreed by AstraZeneca. The Anglo-Swedish company revised down the timetable last month because of production issues, leading to a bitter fight with the EU over delayed supplies.
Under the confidential contract, only parts of which had previously been disclosed, the EU has agreed to pay approximately 2.9 euros ($3.5) per dose, in line with Reuters’ earlier reports of a price of about 2.5 euros.
The document, published by a team of RAI investigative journalists, shows that AstraZeneca had committed to delivering between 80 million and 120 million doses by the end of March and the remaining 180 million shots by the end of June under an estimated delivery schedule.
AstraZeneca, which developed the vaccine with Oxford University, declined to comment.
The company last month cut its planned deliveries in the first quarter of the year to 31 million, and later lifted it to 40 million after intense pressure from the EU.
In another section of the contract, the company committed to use its “best reasonable efforts” to produce and deliver after authorisation approximately 30 million to 40 million doses in 2020 and 80 million to 100 million in the first three months of this year.
The contract shows that the vaccine should be produced for the EU at four factories: one in Belgium, one in the Netherlands and at Oxford Biomedica and Cobra Biologics plants in Britain.